379 related articles for article (PubMed ID: 9734140)
1. Clinical application of fibrinolysis laboratory tests: a review.
Prisco D; Conti AA; Giurlani L; Falciani M
Ann Ital Med Int; 1998; 13(2):81-7. PubMed ID: 9734140
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
3. Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity.
Agren A; Wiman B; Schulman S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):657-60. PubMed ID: 17890953
[TBL] [Abstract][Full Text] [Related]
4. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
5. [Molecular markers for the blood coagulation and fibrinolysis].
Okajima K
Rinsho Byori; 2001 Mar; Suppl 115():74-90. PubMed ID: 11391940
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
7. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
8. [Application of hemostatic molecular markers for diagnosis of thrombosis].
Wada H; Sakakura M; Nobori T; Shiku H
Rinsho Byori; 2000 Apr; 48(4):301-7. PubMed ID: 10810874
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis and the risk of venous and arterial thrombosis.
Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
[TBL] [Abstract][Full Text] [Related]
10. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
Andreenko GV
Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
[TBL] [Abstract][Full Text] [Related]
11. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of molecular markers in hemostasis and thrombosis.
Bick RL
Semin Thromb Hemost; 1984 Oct; 10(4):290-3. PubMed ID: 6515423
[TBL] [Abstract][Full Text] [Related]
13. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
14. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
[TBL] [Abstract][Full Text] [Related]
15. Hereditary defects in fibrinolysis associated with thrombosis.
Hong JJ; Kwaan HC
Semin Thromb Hemost; 1999; 25(3):321-31. PubMed ID: 10443962
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
17. [Anatomical and medical laboratory parallels of various forms of thrombus formation].
Angelov A; Alachverdjan RP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):414-22. PubMed ID: 2444516
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of thrombophilic states.
Mammen EF
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):243-52. PubMed ID: 2465210
[TBL] [Abstract][Full Text] [Related]
19. [Fibrinolytic system and a central retinal vein thrombosis].
Malukiewicz-Wiśniewska G
Klin Oczna; 1998; 100(3):175-8. PubMed ID: 9814003
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
